SIREN : 377679634
CLINITEX SERVICES is a French company founded 36 years ago, specialized in the sector Activités des sociétés holding. Based in VILLENEUVE-D'ASCQ (59491), this company of category ETI shows in 2024 a revenue of 4.7 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2020 | 2019 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4 749 442 € | 4 128 787 € | 3 606 932 € | 3 226 256 € | 2 879 136 € | 2 259 643 € | 2 839 788 € | 2 172 164 € |
| Net income | 1 355 421 € | 1 211 351 € | 1 413 478 € | 1 854 813 € | 1 397 092 € | 1 820 645 € | 1 357 260 € | 760 352 € |
| EBITDA | -143 019 € | -256 279 € | -71 444 € | 54 253 € | 1 897 € | 90 752 € | 127 970 € | 119 126 € |
| Net margin | 28.5% | 29.3% | 39.2% | 57.5% | 48.5% | 80.6% | 47.8% | 35.0% |
In 2024, CLINITEX SERVICES achieves revenue of 4.7 M€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +10.3%. Vs 2023, growth of +15% (4.1 M€ -> 4.7 M€). After deducting consumption (-145 k€), gross margin stands at 4.9 M€, i.e. a rate of 103%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -143 k€, representing -3.0% of revenue. Positive scissor effect: EBITDA margin improves by +3.2 pts, sign of improved operational efficiency. Negative EBITDA means operations do not cover current expenses: concerning situation. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 1.4 M€, i.e. 28.5% of revenue. This profit can be retained or distributed to shareholders.
4 749 442 €
4 894 762 €
-143 019 €
-305 519 €
1 355 421 €
-3.0%
The debt ratio (= Financial debt / Equity x 100) stands at 143%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 38%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 9.3 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 30.0% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
142.521%
38.266%
29.998%
9.343
76.7%
In 2024, the debt ratio of CLINITEX SERVICES (142.52) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of CLINITEX SERVICES (38.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of CLINITEX SERVICES (9.34) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 600.51. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
600.512
-118.078
In 2024, the liquidity ratio of CLINITEX SERVICES (600.51) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2024, the interest coverage of CLINITEX SERVICES (-118.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 9 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 65 days. Excellent situation: suppliers finance 56 days of the operating cycle (retail model). Inventory turnover is 17 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 343 days of revenue, i.e. 4.5 M€ to permanently finance. Over 2016-2024, WCR increased by +323%, requiring additional financing.
4 521 849 €
9 j
65 j
17 j
343 j
Based on 54 transactions of similar company sales
in 2024,
the value of CLINITEX SERVICES is estimated at
2 469 347 €
(range 1 548 639€ - 6 043 754€).
The price/revenue ratio is 0.59x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 54 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare CLINITEX SERVICES with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sociétés holding
The revenue of CLINITEX SERVICES in 2024 is 4.7 M€.
Yes, CLINITEX SERVICES generated a net profit of 1.4 M€ in 2024.
The headquarters of CLINITEX SERVICES is located in VILLENEUVE-D'ASCQ (59491), in the department Nord.
The tax return of CLINITEX SERVICES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
CLINITEX SERVICES operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.